463P - Real-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study
| Autor: | O’Connor, J.M., Ducreux, M., Petersen, L.N., Öhler, L., Bergamo, F., Metges, J.-P., de Groot, J.W., Wang, J.-Y., García Paredes, B., Dochy, E., Fiala-Buskies, S., Cervantes, A., Falcone, A. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|